David Wilson

Molecular Detection, Inc. develops and commercializes molecular diagnostic tests to detect infectious diseases. It offers Detect-Ready methicillin-resistant Staphylococcus aureus (MRSA) panel that allows for the detection of MRSA. The company was founded by Aryeh L. Gassel in 2007 and is headquartered in Wayne, PA.

Vitro Biopharma, Inc. develops and commercializes adult stem cell technology for applications in stem cell research, drug development and therapeutic products for treatment a vast variety of diseases and conditions. Its products include cell culture media, cell lines, and nutravivo-dietary-supplements. The company was founded by James R. Musick on March 31, 1986 and is headquartered in Denver, CO.

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

Part of Roche Holding AG, Boehringer Mannheim Diagnostics Corp. develops and manufactures personal diagnostic devices. The company is based in Houston, TX.

HiberGene Diagnostics Ltd. develops, manufactures, and markets molecular diagnostic tests for human infectious diseases. Its products include Loop Mediated Isothermal Amplification (LAMP) technology, HG swift, HG meningococcus, pipeline, and HG group B streptococcus. The company was founded by Brendan K. Farrell, Peter William Kidney, Peter Valentine Coyle, Derek J. Fairley, and Joe Kidney in November 2009 and is headquartered in Dublin, Ireland.